NextGen Jane Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $7.02M

  • Investors
  • 15

NextGen Jane General Information

Description

Developer of diagnostic tools designed to offer information and data on women's reproductive health. The company's tools use a patented tampon collection technology to transform the diverse molecular signals from the endometrium, cervix, fallopian tubes, and ovaries shed during menstruation into digital diagnoses for in-depth sequencing analysis and disease detection, enabling women to send their menstrual samples and predict reproductive diseases in a hassle-free manner.

Contact Information

Formerly Known As
NextGenJane
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 400 29th Street
  • Suite 105
  • Oakland, CA 94609
  • United States
+1 (415)
Primary Industry
Other Devices and Supplies
Other Industries
Medical Supplies
Vertical(s)
Corporate Office
  • 400 29th Street
  • Suite 105
  • Oakland, CA 94609
  • United States
+1 (415)

NextGen Jane Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NextGen Jane Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 02-Oct-2023 $7.02M Completed Generating Revenue
4. Later Stage VC 09-Jun-2022 Completed Generating Revenue
3. Later Stage VC (Series A) 29-Mar-2019 Completed Startup
2. Seed Round 09-Mar-2016 $2.22M $2.22M Completed Startup
1. Accelerator/Incubator 09-Dec-2015 Completed Startup
To view NextGen Jane’s complete valuation and funding history, request access »

NextGen Jane Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
Seed
To view NextGen Jane’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

NextGen Jane Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of diagnostic tools designed to offer information and data on women's reproductive health. The company's tools
Other Devices and Supplies
Oakland, CA
10 As of 2025

Wijnegem, Belgium
 

Trumbull, CT
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

NextGen Jane Competitors (7)

One of NextGen Jane’s 7 competitors is Novosanis, a Formerly VC-backed company based in Wijnegem, Belgium.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Novosanis Formerly VC-backed Wijnegem, Belgium
CooperSurgical Corporate Backed or Acquired Trumbull, CT
Genomic Expression Venture Capital-Backed Beverly, MA
Illumina Formerly VC-backed San Diego, CA
Living DNA Corporation Frome, United Kingdom
You’re viewing 5 of 7 competitors. Get the full list »

NextGen Jane Patents

NextGen Jane Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4267009-A1 Systems and methods for preservation of a cervicovaginal fluid sample Pending 23-Dec-2020
US-20240041439-A1 Systems and methods for preservation of a cervicovaginal fluid sample Pending 23-Dec-2020
EP-4267009-A4 Systems and methods for preservation of a cervicovaginal fluid sample Pending 23-Dec-2020
US-20230257698-A1 Fetal trophoblast compositions and methods Pending 07-Jul-2020
EP-4179117-A1 Fetal trophoblast compositions and methods Pending 07-Jul-2020 A61B10/0291
To view NextGen Jane’s complete patent history, request access »

NextGen Jane Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NextGen Jane Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds
Labcorp Venture Fund Corporate Venture Capital Minority
Access Industries Holding Company Minority
Angel (individual) Minority
Angel (individual) Minority
Angel (individual) Minority
You’re viewing 5 of 15 investors. Get the full list »

NextGen Jane FAQs

  • When was NextGen Jane founded?

    NextGen Jane was founded in 2014.

  • Where is NextGen Jane headquartered?

    NextGen Jane is headquartered in Oakland, CA.

  • What is the size of NextGen Jane?

    NextGen Jane has 10 total employees.

  • What industry is NextGen Jane in?

    NextGen Jane’s primary industry is Other Devices and Supplies.

  • Is NextGen Jane a private or public company?

    NextGen Jane is a Private company.

  • What is NextGen Jane’s current revenue?

    The current revenue for NextGen Jane is .

  • How much funding has NextGen Jane raised over time?

    NextGen Jane has raised $19.6M.

  • Who are NextGen Jane’s investors?

    Labcorp Venture Fund, Access Industries, , , and are 5 of 15 investors who have invested in NextGen Jane.

  • Who are NextGen Jane’s competitors?

    Novosanis, CooperSurgical, Genomic Expression, Illumina, and Living DNA are some of the 7 competitors of NextGen Jane.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »